Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Deferred Revenue

$220.40M

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Deferred Revenue

Latest reported$220.40Mperiod endingJun 30, 2026

Latest reported$220.40Mperiod endingJun 30, 2026

REGN Quarterly Deferred Revenue ($0.00 → $220.40M)

Quarterly deferred revenue

High-resolution chart · PNG

REGN deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Deferred Revenue — Quarterly (USD)
Period ending	Deferred Revenue (USD)
Jun 30, 2001	4,054,000
Mar 31, 2001	3,682,000
Dec 31, 2000	0
Sep 30, 2000	0
Jun 30, 2000	0
Mar 31, 2000	0
Dec 31, 1999	0
Sep 30, 1999	0
Jun 30, 1999	0
Mar 31, 1999	0
Dec 31, 1998	0
Sep 30, 1998	0
Jun 30, 1998	0
Mar 31, 1998	0
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	0
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.